Menu Search
Equities

Deltex Medical Group PLC

DEMG:LSE

Deltex Medical Group PLC

Actions
Health CareMedical Equipment and Services
  • Price (GBX)0.09
  • Today's Change0.00 / 0.00%
  • Shares traded251.23k
  • 1 Year change-40.00%
  • Beta0.8518
Data delayed at least 20 minutes, as of Nov 08 2024 15:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Deltex Medical Group PLC's revenues fell -28.44% from 2.48m to 1.78m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a loss of 1.15m to a larger loss of 1.28m.
Gross margin62.21%
Net profit margin-72.60%
Operating margin-60.47%
Return on assets-22.92%
Return on equity-53.85%
Return on investment-35.89%
More ▼

Cash flow in GBPView more

In 2023, Deltex Medical Group PLC increased its cash reserves by 49.68%, or 234.00k. Cash Flow from Financing totalled 1.79m or 100.56% of revenues. In addition the company used 1.20m for operations while cash used for investing totalled 370.00k.
Cash flow per share-0.0006
Price/Cash flow per share--
Book value per share0.0015
Tangible book value per share-0.0006
More ▼

Balance sheet in GBPView more

Deltex Medical Group PLC has a Debt to Total Capital ratio of 42.45%, a lower figure than the previous year's 58.47%.
Current ratio0.8898
Quick ratio0.4855
Total debt/total equity0.6995
Total debt/total capital0.4245
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.